Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
Clinical trial NCT00156312 · COMPLETED
Trial details
- NCT number
- NCT00156312
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2005-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.